Omada Health, Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
4. Consolidated Balance Sheet Components
- Consolidated Balance Sheet Components
Accounts Receivable, Net
Accounts receivable, net consists of the following (in thousands):
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| Billed accounts receivable | $24,616 | $13,563 |
| Unbilled accounts receivable | 27,000 | 22,182 |
| Allowance for credit losses | (3,423) | (1,160) |
| Total accounts receivable, net | $48,193 | $34,585 |
A roll forward of the Company’s allowance for credit losses is as follows (in thousands):
| Three Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Balance at beginning of period | $(1,835) | $(1,418) |
| Provision for credit losses, net | (1,127) | (995) |
| Other adjustments and write-offs | (461) | 1,127 |
| Balance at end of period | $(3,423) | $(1,286) |
| Nine Months Ended September 30, | ||
| 2026 | 2025 | |
| Balance at beginning of period | $(1,160) | $(1,985) |
| Provision for credit losses, net | (2,316) | (1,485) |
| Other adjustments and write-offs | 53 | 2,184 |
| Balance at end of period | $(3,423) | $(1,286) |
Inventory
Inventory is comprised of finished goods inventory. There wasno reserve for excess and obsolete inventory recorded as of September 30, 2026 and December 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.